Home Tools
Log in
Cart

Leukotriene Receptor

The leukotriene (LT) receptors are G protein-coupled receptors that bind and are activated by the leukotrienes.
Cat. No. Product name CAS No. Purity Chemical Structure
T0694 Pranlukast 103177-37-3 98%
Pranlukast is a cysteinyl leukotriene receptor-1 antagonist. It antagonizes or reduces bronchospasm caused, principally in asthmatics, by an allergic reaction to...
TN1182 11-​Keto-​beta-​boswellic acid 17019-92-0 98%
11-Keto-beta-boswellic acid, a novel Nrf2 activator, and a selective 5-lipoxygenase (5-LOX) inhibitor; it exerts dose dependent cardioprotective effect manifeste...
T27979 Masilukast 136564-68-6 98%
Masilukast(MCC-847) is an oral leukotriene D4 (LTD4) receptor antagonist for the study of diseases associated with inflammation.
T22946 LY255283 117690-79-6 98%
LY 255283 is a specific antagonit of leukotriene B4 (LTB4) receptor. It inhibits the production of LTB(4) in human peripheral blood polymorphonuclear leukocytes ...
T1677L Montelukast sodium 151767-02-1 98%
Montelukast is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma and has been linked t...
T24327 L 674573 127481-29-2 98%
L 674573 is an inhibitor of leukotriene biosynthesis.
T26519 Ablukast 96566-25-5 98%
Ablukast is a leuktriene receptor antagonist. Ablukast acts as an anti-asthmatic.
T22358 Etalocib 161172-51-6 98%
Etalocib is a novel diaryl ether carboxylic acid derivative, is a selective and potent inhibitor of the lipoxygenase pathway either via antagonism of the leukotr...
T30828 CGP 35949 111130-13-3 98%
CGP 35949 is an LTD4 antagonist with phospholipase inhibitory activity.
T14387 AZD9898 2042347-69-1 98%
AZD9898 is an inhibitor of leukotriene-C4 synthetase with an IC50 of 0.28 nM. AZD9898 can be used in studies about asthma. AZD9898 mitigates the GABA binding and...
T26524 ABT-080 189498-57-5 98%
ABT-080, a leukotriene synthesis inhibitor, is used potentially for treatment of asthma.
T5714 5-O-Demethylnobiletin 2174-59-6 98%
5-DEMETHYLNOBILETIN is a natual product, has anti-inflammatory activity, it may act through a direct inhibition of 5-LOX, without affecting the expression of COX...
T3148 MK-571 sodium 115103-85-0 98%
MK-571 is a selective, orally active antagonist of the CysLT1 receptor. MK571 is a multidrug resistance protein-2 (ABCC2, Mrp2) inhibitor used to demonstrate the...
T1677 Montelukast 158966-92-8 98%
Montelukast is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma and has been linked t...
T16280 Nedocromil 69049-73-6 98%
Nedocromil inhibits the action or formation of multiple mediators. Which including histamine, leukotriene C4 (LTC4), and prostaglandin D2 (PGD2).
T23390 SR 2640 hydrochloride 146662-42-2 98%
SR 2640 hydrochloride is a competitive antagonist of leukotriene D4 and E4 and can be used in studies about leukotrienes in human asthma.
T6736 Zafirlukast 107753-78-6 98%
Zafirlukast is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma.
T6893 MK-886 118414-82-7 98%
MK-886 is an inhibitor of leukotriene biosynthesis, inhibiting 5-lipoxygenase-activating protein (FLAP). It is also a moderately potent PPARα antagonist.
Pranlukast
T0694
Pranlukast is a cysteinyl leukotriene receptor-1 antagonist. It antagonizes or reduces bronchospasm caused, principally in asthmatics, by an allergic reaction to...
11-​Keto-​beta-​boswellic acid
TN1182
11-Keto-beta-boswellic acid, a novel Nrf2 activator, and a selective 5-lipoxygenase (5-LOX) inhibitor; it exerts dose dependent cardioprotective effect manifeste...
Masilukast
T27979
Masilukast(MCC-847) is an oral leukotriene D4 (LTD4) receptor antagonist for the study of diseases associated with inflammation.
LY255283
T22946
LY 255283 is a specific antagonit of leukotriene B4 (LTB4) receptor. It inhibits the production of LTB(4) in human peripheral blood polymorphonuclear leukocytes ...
Montelukast sodium
T1677L
Montelukast is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma and has been linked t...
L 674573
T24327
L 674573 is an inhibitor of leukotriene biosynthesis.
Ablukast
T26519
Ablukast is a leuktriene receptor antagonist. Ablukast acts as an anti-asthmatic.
Etalocib
T22358
Etalocib is a novel diaryl ether carboxylic acid derivative, is a selective and potent inhibitor of the lipoxygenase pathway either via antagonism of the leukotr...
CGP 35949
T30828
CGP 35949 is an LTD4 antagonist with phospholipase inhibitory activity.
AZD9898
T14387
AZD9898 is an inhibitor of leukotriene-C4 synthetase with an IC50 of 0.28 nM. AZD9898 can be used in studies about asthma. AZD9898 mitigates the GABA binding and...
ABT-080
T26524
ABT-080, a leukotriene synthesis inhibitor, is used potentially for treatment of asthma.
5-O-Demethylnobiletin
T5714
5-DEMETHYLNOBILETIN is a natual product, has anti-inflammatory activity, it may act through a direct inhibition of 5-LOX, without affecting the expression of COX...
MK-571 sodium
T3148
MK-571 is a selective, orally active antagonist of the CysLT1 receptor. MK571 is a multidrug resistance protein-2 (ABCC2, Mrp2) inhibitor used to demonstrate the...
Montelukast
T1677
Montelukast is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma and has been linked t...
Nedocromil
T16280
Nedocromil inhibits the action or formation of multiple mediators. Which including histamine, leukotriene C4 (LTC4), and prostaglandin D2 (PGD2).
SR 2640 hydrochloride
T23390
SR 2640 hydrochloride is a competitive antagonist of leukotriene D4 and E4 and can be used in studies about leukotrienes in human asthma.
Zafirlukast
T6736
Zafirlukast is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma.
MK-886
T6893
MK-886 is an inhibitor of leukotriene biosynthesis, inhibiting 5-lipoxygenase-activating protein (FLAP). It is also a moderately potent PPARα antagonist.